menu
    • menu

    Company profile for Rigel Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rigel Pharmaceuticals, Inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel's pioneering research focuses on signaling pathways that are critical to disease mechanisms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rigel PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1180 Veterans Blvd South San Francisco, CA 94080
    Telephone
    Telephone
    650.624.1100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rigel.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rigel to Present at Piper Sandler Healthcare Conference
    Rigel to Present at Piper Sandler Healthcare Conference

    26 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigel-to-present-at-the-piper-sandler-37th-annual-healthcare-conference-302626268.html

    PR NEWSWIRE
    26 Nov 2025
    Share Share
    Rigel Publishes 5-Year Rezlidhia Data in R/R mIDH1 AML
    Rigel Publishes 5-Year Rezlidhia Data in R/R mIDH1 AML

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigel-announces-publication-of-final-5-year-data-on-rezlidhia-olutasidenib-in-patients-with-rr-midh1-aml-in-the-journal-of-hematology--oncology-302616427.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Rigel To Present At Jefferies Global Healthcare Conference
    Rigel To Present At Jefferies Global Healthcare Conference

    12 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-global-healthcare-conference-in-london-302612245.html

    PR NEWSWIRE
    12 Nov 2025
    Share Share
    Lilly Pulls Out Of CNS Portion Of $960M Collab With Rigel
    Lilly Pulls Out Of CNS Portion Of $960M Collab With Rigel

    06 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lilly-pulls-out-cns-portion-950m-rirpk1-inhibitor-collab-rigel

    FIERCE BIOTECH
    06 Nov 2025
    Share Share
    Rigel Reports Q3 2025 Financials & Business Update
    Rigel Reports Q3 2025 Financials & Business Update

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigel-reports-third-quarter-2025-financial-results-and-provides-business-update-302604504.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Rigel Presents Five Studies at ASH Annual Meeting
    Rigel Presents Five Studies at ASH Annual Meeting

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rigel-announces-one-oral-and-four-poster-presentations-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition-302602603.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search